The Enterprise Value as of June 2026 (TTM) for Artiva Biotherapeutics, Inc. (ARTV) is 200.39M

According to Artiva Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 200.39M. This represents a change of 154.17% compared to the average of 78.84M of the last 4 quarters.

Artiva Biotherapeutics, Inc. (ARTV) Historical Enterprise Value (quarterly & annually)

How has ARTV Enterprise Value performed in the past?

The mean historical Enterprise Value of Artiva Biotherapeutics, Inc. over the last ten years is 132.14M. The current 200.39M Enterprise Value has changed 15.07% with respect to the historical average. Over the past ten years (40 quarters), ARTV's Enterprise Value was at its highest in in the September 2024 quarter at 334.32M. The Enterprise Value was at its lowest in in the March 2023 quarter at 0.

Artiva Biotherapeutics, Inc. (ARTV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Artiva Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Artiva Biotherapeutics, Inc. (ARTV) Average Enterprise Value

How has ARTV Enterprise Value performed in the past?

The current Enterprise Value of Artiva Biotherapeutics, Inc. (ARTV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Artiva Biotherapeutics, Inc. (ARTV) Enterprise Value vs. Peers

How is ARTV’s Enterprise Value compared to its peers?

Artiva Biotherapeutics, Inc.’s Enterprise Value is greater than Precision BioSciences, Inc. (7.35M), greater than Adverum Biotechnologies, Inc. (159.14M), less than Sutro Biopharma, Inc. (218.65M), greater than Fractyl Health, Inc. Common Stock (59.01M), greater than ALX Oncology Holdings Inc. (185.54M), greater than InflaRx N.V. (85.69M), less than Zentalis Pharmaceuticals, Inc. (269.67M), greater than Metagenomi, Inc. Common Stock (59.06M), greater than Connect Biopharma Holdings Limited (95.83M), greater than Shattuck Labs, Inc. (148.26M),

Build a custom stock screener for Artiva Biotherapeutics, Inc. (ARTV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Artiva Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Artiva Biotherapeutics, Inc. (ARTV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Artiva Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.